Using Mobile Technologies to Fight Chronic Disease

01.09.14 | By

Technology is rapidly changing how we conduct even the simplest of daily tasks, and with smartphones, tablets, and other mobile devices, being “connected” is no longer a function of sitting at a desk in front of a computer. We now carry some of the most powerful computers in the palm of our hands, and mobile platforms have opened the door to the creation of some incredibly innovative applications.

Truth is, Science is Expensive

01.09.14 | By

Earlier this week, Scientific American published an excellent blog post by chemist Ashutosh Jogalekar with the cheeky title, “Why drugs are expensive: It’s the science, stupid.” In his well-informed commentary, Jogalekar describes an issue that has faced industry for some time:

Data on Retail Prescription Drug Spending

01.08.14 | By

Looking for the latest data on retail prescription drug spending? We’ve got it here. Yesterday, CMS’ Office of the Actuary released its latest figures on national health care and prescription drug spending for 2012.

Scientific Leadership Advisory Council – Delivering Solutions

01.08.14 | By

This is the third blog post in a series of responses to Luke Timmerman’s Xconomy article, “12 Things the Pharma Industry Can Do to Rebuild Real Public Trust,” in which he says the pharmaceutical industry isn’t doing enough to deliver “big health advances.”

STEM Education

01.07.14 | By

A recent article in Information Week authored by Robert Atkinson, President of the Information Technology and Innovation Foundation, makes an interesting argument about why innovation-focused industries, such as the biopharmaceutical sector, should come together on issues of innovation in order to maintain U.S. competitiveness.

STEM Saves Lives Agenda

Joint EFPIA-PhRMA Principles for Responsible Clinical Trial Data Sharing Become Effective Today

Brussels and Washington, D.C (January 1, 2014) — The European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) are pleased to announce that implementation of the joint Principles for Responsible Clinical Trial Data Sharing begins today.

India and Intellectual Property

Washington, D.C. (December 30, 2013) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matt Bennett provided the following statement:

New Medicine Approvals in 2012

New Report Shows Minnesota Clinical Trials Benefit Patients, State Economy and Science

MINNEAPOLIS, MN (December 13, 2013) – Working with Minnesota research institutions, including the members of the Minnesota Clinical Research Alliance (MCRA), the nation's biopharmaceutical research companies have conducted 2,945 clinical trials of new medicines since 1999, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).  This total reflects an increase of about 300 trials over the last year.

Pages

Subscribe to RSS - Innovation